McKesson Corp.

• Introduction
• Chapter 1 The Birth of McKesson: From Apothecary Roots to Wholesaler
• Chapter 2 Olcott, McKesson & Co.: Early Partnerships and Expansion
• Chapter 3 Into the Industrial Age: Growth and Innovation in the 19th Century
• Chapter 4 Surviving Wars and Pandemics: The Early 20th Century
• Chapter 5 The McKesson & Robbins Scandal: Crisis and Reform
• Chapter 6 Postwar Rebuilding: Mergers and the Path to Leadership
• Chapter 7 Foremost-McKesson: Diversification and Transformation
• Chapter 8 McKesson in the Deregulation Era: Navigating Change
• Chapter 9 The Rise to Market Leadership in Drug Distribution
• Chapter 10 A Series of Strategic Acquisitions
• Chapter 11 HBO & Company: Ambition, Turmoil, and Recovery
• Chapter 12 Expanding Northward: The McKesson Canada Story
• Chapter 13 New Frontiers: European Expansion and the Celesio Acquisition
• Chapter 14 IT Innovations and the Move Toward Healthcare Technology
• Chapter 15 Oncology and Specialty Care: Building New Networks
• Chapter 16 The Power of Data: AI, Cloud, and Analytics Transformation
• Chapter 17 The Four Segments: Structure of a Modern Healthcare Giant
• Chapter 18 Leadership Through the Decades: Guiding McKesson’s Evolution
• Chapter 19 Corporate Culture: ICARE Principles and ILEAD Leadership
• Chapter 20 Social Responsibility and Community Engagement
• Chapter 21 Environmental Sustainability: McKesson’s Green Commitment
• Chapter 22 Financial Performance: Metrics of Growth and Value
• Chapter 23 The COVID-19 Era: Response and Resilience
• Chapter 24 Current Challenges and the Competitive Healthcare Landscape
• Chapter 25 The Future of McKesson: Innovation, Vision, and Impact

McKesson Corporation stands as a testament to the enduring power of adaptation and vision in the landscape of American enterprise. Founded nearly two centuries ago, McKesson has grown from its origins as a modest importer and wholesaler of botanical drugs in New York City to one of the world’s largest and most influential healthcare companies. Its journey is not just a reflection of business success, but a lens through which we can examine the evolution of healthcare, commerce, and corporate responsibility in the United States.

Throughout its history, McKesson has continuously adapted to the major shifts that shaped both the American economy and the healthcare industry. From surviving the turbulence of wars and pandemics, to responding to the waves of regulation and deregulation that transformed business practices, the company’s resilience has become an essential part of its identity. Key turning points, such as the infamous McKesson & Robbins scandal, have tested the organization’s capacity to not only endure adversity but to drive industry reform and elevate standards.

The story of McKesson is intricately tied to the innovations that have defined the modern healthcare supply chain. The company’s relentless pursuit of efficiency, reliability, and technological advancement has enabled it to connect manufacturers, providers, and patients across an extensive network. With ventures into information technology, data analytics, artificial intelligence, and cloud infrastructure, McKesson has consistently stayed ahead of the technological curve, shaping the way medicines and healthcare solutions reach millions of people every day.

Equally significant is McKesson’s commitment to the people and communities it serves. The company’s values, championed through the ICARE and ILEAD principles, foster a culture that prizes integrity, inclusion, and excellence. Corporate social responsibility initiatives, environmental sustainability programs, and robust community engagement efforts have become central to McKesson’s role in society, demonstrating that its influence extends far beyond the bottom line.

As McKesson sets its sights on the future, it faces challenges and opportunities that will test its ability to innovate and lead. Competition in the healthcare landscape grows fiercer, regulatory complexities evolve, and the demands placed on healthcare supply chains become ever more critical. Yet, the same spirit of ambition and commitment that has driven the company since 1828 remains a guiding force as McKesson prepares to shape the next era of healthcare.

This book explores the rich history, present operations, and future prospects of McKesson Corporation. Through careful research and analysis, it aims to provide not only a chronicle of a remarkable American company, but also insights into the broader forces that continue to shape the healthcare industry and, by extension, the lives of people around the world.

The story of McKesson Corporation, a titan in the modern healthcare industry, begins not in gleaming corporate towers or high-tech distribution centers, but in the bustling streets of early 19th-century New York City. It was 1828 when Charles M. Olcott, an apothecary by training, laid the groundwork for what would become a formidable enterprise. Olcott, a pharmacist by trade, was not just dispensing remedies; he was actively involved in providing medical advice and even occasional surgical and midwifery services, a testament to the broad scope of apothecaries in that era. His initial venture was a successful semi-jobbing business, selling products in wholesale quantities from his location at the corner of Madison and Catherine streets.

The pharmaceutical landscape of the 1800s was a far cry from today's highly regulated and specialized industry. Botanical drugs, derived from plants, formed the backbone of medicine. These natural remedies, ranging from herbs to vegetable extracts, were the primary tools available to treat ailments and were widely imported and traded. It was into this burgeoning market that Olcott's business steadily grew, establishing a foothold in the importing and wholesale trade of these essential botanical products.

A pivotal moment arrived in 1833 when Olcott partnered with John McKesson, a young and ambitious entrepreneur. This collaboration marked the official formation of Olcott, McKesson & Co., and the firm established its headquarters at 145 Maiden Lane, a prime location within Manhattan's wholesale district. Their business model was straightforward yet effective: they were importers and wholesalers of botanical drugs, bringing in goods from overseas and distributing them to a growing network of customers. The company's initial clientele even included captains of the tall-masted clipper ships that docked nearby, highlighting the centrality of New York as a hub for commerce and the importance of imported goods.

The partnership between Olcott and McKesson proved to be a synergistic one. Olcott brought his expertise in apothecary and the practical aspects of the drug trade, while McKesson's entrepreneurial spirit undoubtedly fueled the company's early expansion. They quickly earned a reputation for reliability and quality, essential attributes in an industry where the efficacy of products directly impacted public health. Their focus on the wholesale of botanical-based drugs, including herbs and vegetable extracts, cemented their position as a key supplier in the nascent American healthcare market.

Beyond just botanical remedies, Olcott, McKesson & Co. also began to offer therapeutic drugs and chemicals. This expansion of their product line to include items like acids, elixirs, tinctures, and essential oils demonstrated a foresight into the evolving needs of their customers and the broader medical community. This diversification was crucial for the company's long-term growth, as it allowed them to cater to a wider array of medical practices and demands.

The firm's operations were a microcosm of 19th-century commerce. Goods arrived from distant lands, were meticulously processed and cataloged, and then dispatched to various apothecaries, doctors, and other distributors across the burgeoning nation. This early supply chain, while rudimentary by today's standards, was vital for connecting sources of medicine with the communities that desperately needed them. The company effectively served as a central nervous system for the distribution of medicinal products in a time when communication and transportation were far from instantaneous.

The early years saw Olcott, McKesson & Co. steadily gain prominence. They were not merely traders; they were facilitators of health, ensuring that essential medicines reached communities, often long distances from the port of New York. The demand for reliable sources of drugs was constant, and the company positioned itself as a trusted intermediary in a market that was still largely unregulated and fragmented. The foundation they were building was not just a business, but a critical piece of the emerging national healthcare infrastructure.

As the years progressed, the company became more than just an importer. By 1855, McKesson & Robbins, as it would soon be known, had already begun to manufacture its own drugs. This was a significant step, transitioning from solely distributing what others produced to actively creating pharmaceutical products. This move into manufacturing allowed for greater control over quality and supply, further solidifying their position in the market. Their early manufactured products, such as fluid extracts, tinctures, pills, and tablets, even garnered recognition and awards for their pioneering nature.

The commitment to both wholesale distribution and manufacturing set a precedent for McKesson's future strategy: a blend of efficient logistics and direct involvement in product creation. This dual approach allowed them to capture more of the value chain and respond more dynamically to market needs. The company's early success underscored the growing demand for organized and reliable sources of medicine as the United States continued its rapid expansion.

The vision of Charles Olcott and John McKesson in those formative years laid the bedrock for a company that would not only endure but thrive through centuries of change. Their initial foray into the world of botanical drugs and their expansion into manufacturing marked the true birth of a healthcare giant. They established principles of reliability and a commitment to meeting the healthcare needs of a growing nation, principles that would continue to guide McKesson through its long and remarkable history.